These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3062773)

  • 1. [Intensified insulin therapy in Type 1 diabetes. Results of a 1-year treatment using the basic-bolus principle in hard-to-control diabetic patients].
    Spinas GA; Straumann E; Jäggi E; Berger W
    Schweiz Med Wochenschr; 1988 Dec; 118(51):1946-9. PubMed ID: 3062773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intensive insulin therapy in adolescents with type 1 diabetes mellitus: initial experiences with a semiautomatic insulin injection device (the insulin pen)].
    Schönle EJ
    Schweiz Med Wochenschr; 1987 Nov; 117(45):1756-60. PubMed ID: 3321425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin therapy of Type I diabetes].
    Berger W
    Ther Umsch; 1996 Dec; 53(12):902-13. PubMed ID: 9036568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
    Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of metabolic and psychological parameters during continuous subcutaneous insulin infusion and intensified conventional insulin treatment in type I diabetic patients.
    Schottenfeld-Naor Y; Galatzer A; Karp M; Josefsberg Z; Laron Z
    Isr J Med Sci; 1985 Oct; 21(10):822-8. PubMed ID: 3908396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen-injector.
    Hardy KJ; Jones KE; Gill GV
    Diabet Med; 1991 Jan; 8(1):69-71. PubMed ID: 1826248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.
    van Meijel LA; van den Heuvel-Bens SP; Zimmerman LJ; Bazelmans E; Tack CJ; de Galan BE
    Clin Ther; 2018 Jun; 40(6):862-871. PubMed ID: 29502804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.
    Lager I; Lönnroth P; von Schenck H; Smith U
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1661-4. PubMed ID: 6416540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
    Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
    Diabet Med; 2002 Sep; 19(9):746-51. PubMed ID: 12207811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multi-injection treatment using an insulin pen].
    Foss NE; Gustavsen I; Støa K
    Tidsskr Nor Laegeforen; 1990 Mar; 110(7):833-4. PubMed ID: 2181729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin therapy using a new injection device. Experience with 36 type I diabetics].
    Stracke H; Federlin K
    Dtsch Med Wochenschr; 1987 Mar; 112(10):385-8. PubMed ID: 3545743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.
    Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY
    Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood glucose self-monitoring in intensified insulin therapy: acceptance of frequent measurements and effect on quality of diabetic control].
    Weitgasser R; Schnöll F; Pretsch I; Gruber U; Sailer S
    Acta Med Austriaca; 1998; 25(2):61-4. PubMed ID: 9681045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary application of a new bolus insulin model for type 1 diabetes.
    Pelzer R; Mathews EH; Liebenberg L
    Diabetes Technol Ther; 2011 May; 13(5):527-35. PubMed ID: 21410336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.